# Xeris Pharmaceuticals (stock symbol: XERS) Logo in transparent PNG and SVG formats

## Xeris Pharmaceuticals Logo large

### Xeris Pharmaceuticals Logo large Download PNG (49.74 KB)

![Xeris Pharmaceuticals Logo large Download PNG (49.74 KB)](/img/orig/XERS_BIG-6d09cbc1.png)

### Xeris Pharmaceuticals Logo large Download SVG (5.65 KB)

![Xeris Pharmaceuticals Logo large Download SVG (5.65 KB)](/img/orig/XERS_BIG-eb1d65ab.svg)

## Xeris Pharmaceuticals Logo icon format

### Xeris Pharmaceuticals Logo icon format Download PNG (56.59 KB)

![Xeris Pharmaceuticals Logo icon format Download PNG (56.59 KB)](/img/orig/XERS-fbdaf572.png)

### Xeris Pharmaceuticals Logo icon format Download SVG (1.83 KB)

![Xeris Pharmaceuticals Logo icon format Download SVG (1.83 KB)](/img/orig/XERS-e6b977a9.svg)

## About Xeris Pharmaceuticals

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

1. Website domain: xerispharma.com
2. Employees: 294
3. Marketcap: $0.31 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
